Operation Warp Speed leader says he expects coronavirus vaccine to be highly effective, 'in the 90%' range

Moncef Slaoui, head of the government's effort to develop a vaccine against Covid-19, says he expects the vaccine to have efficacy rates "in the 90%" range -- but that there might not be enough vaccine available for all Americans until the end of next year.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news

Related Links:

A third US company has released study results showing its coronavirus vaccine is safe and elicits an immune response.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
Critical media reporting about Operation Warp Speed, the federal government's effort to speed development of drugs, vaccines and other measures to fight the coronavirus pandemic, is distracting people working on the project, its chief adviser says.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
Gaithersburg ’s Novavax Inc. (NASDAQ: NVAX) reported Tuesday positive phase 1 clinical trial data on its Covid-19 vaccine candidate, a necessary step to advance a product officials hope will eventually protect people from coronavirus. The study found the candidate, called NVX-CoV2373, to both be generally wel l-tolerated and elicit “robust antibody responses,” the company said Tuesday, adding that it showed the potential to reduce the disease’s transmission. Specifically, the candidate had…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
The company has received a $1.6 billion grant from the government ’s Operation Warp Speed to have 100 million doses ready by early 2021.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Clinical Trials Vaccination and Immunization Public-Private Sector Cooperation Coronavirus (2019-nCoV) Research Immune System Novavax Inc Source Type: news
Authors: Lackland DT, Sims-Robinson C, Jones Buie JN, Voeks JH Abstract The randomized clinical trial (RCT) has long been recognized as the 'gold standard' for developing evidence for clinical treatments and vaccines; however, the successful implementation and translation of these findings is predicated upon external validity. The generalization of RCT findings are jeopardized by the lack of participation of at-risk groups such as African Americans, with long-recognized disproportional representation. Distinct factors that deter participation in RCTs include distrust, access, recruitment strategies, perceptions of ...
Source: Ethnicity and Disease - Category: International Medicine & Public Health Tags: Ethn Dis Source Type: research
The experimental mRNA-1273 vaccine, developed by the National Institutes of Health (NIH) and biotech firm Moderna, is one of several promising candidates in the final stretch of the vaccine race.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
With prospects of a Covid-19 vaccine looking up, attention is turning to the problem of anti-vax ideas. The number of conspiracy theories circulating about coronavirus don't help. Here are six rules an expert uses for talking to conspiracy theorists in an effort to change their mind.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
Daniel Griffin provides a clinical report on COVID-19, followed by a review of the findings that children shed as much SARS-CoV-2 viral RNA from the respiratory tract as older patients, the lineage giving rise to SARS-CoV-2 has been circulating in bats in China for decades, and answers to listener questions. Click arrow to playDownload TWiV 648 […]
Source: virology blog - Category: Virology Authors: Tags: This Week in Virology bats coronavirus COVID-19 evolution face mask nasopharyngeal shedding pandemic SARS-CoV-2 vaccine viral viruses Wuhan Yunnan Source Type: blogs
Abstract The unprecedented pandemic of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is threatening global health. The virus emerged in late 2019 and can cause a severe disease associated with significant mortality. Several vaccine development and drug discovery campaigns are underway. The SARS-CoV-2 main protease is considered a promising drug target, as it is dissimilar to human proteases. Sequence and structure of the main protease are closely related to those from other betacoronaviruses, facilitating drug discovery attempts based on previous lead compounds. Covalently binding peptidomimetic...
Source: Bioorganic and Medicinal Chemistry Letters - Category: Chemistry Authors: Tags: Bioorg Med Chem Lett Source Type: research
Pausing to check his map, Sam confirms that he is on the right track for his next delivery, only 2 kilometres left. He takes the opportunity to quench his thirst and check if his delivery load is securely attached to his back; some contain fragile vials of medicines and digital pills susceptible to damage if handled inappropriately. After making sure of the integrity of those packages, Sam takes a final look at his surroundings. “It’s quite peaceful with nobody around,” he thinks to himself and resumes his path.  Upon arrival at his destination, his gear is disinfected before he has access to the ...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Artificial Intelligence Augmented Reality Digital Health Research Healthcare Design Healthcare Policy Telemedicine & Smartphones Virtual Reality fda gamification Fitbit covid19 Apple Watch WHO gaming roche MySugr Foldit A Source Type: blogs
More News: Coronavirus | COVID-19 | Government | Health | Vaccines